Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. Provisional
FDA Flags (4)
Class III RecallMay 2024
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 5
Classification: Class III
Class III RecallMay 2024
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59
Classification: Class III
Class III RecallMay 2024
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (
Classification: Class III
Class III RecallMay 2024
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 5
Classification: Class III